
    
      The primary outcome: Mortality during the 28 day period after randomization. The secondary
      outcomes: Evaluation of SOFA score, ventilator-free days, dialysis free days, catecholamine
      free days, days of hospitalisation, incidence of nosocomial infections.

      The albuminemia of all patients is requested before the treatment until Day 4 post treatment.

      The treatment is: Vialebex 20% 100ml every 8 hours during 3 days versus saline 100ml every 8
      hours during 3 days.

      The first patient will be in July 2006, the last patient expected is on July 2009.
    
  